SINGAPORE, 18 February 2019 – Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”) is pleased to announce that Jeff Chen has been appointed Group Chief Innovation Officer and Head of Capital Markets, based in Hong Kong.
As Group Chief Innovation Officer and Head of Capital Markets, Jeff will serve on the Leadership Team and report to David Sin, Co-Founder and Group President. In these roles, Jeff will work closely with the business development teams across the Group to identify new areas for collaboration and strategic partnerships to leverage synergies and scale in support of Fullerton Health’s purpose of delivering affordable and accessible care for all in Asia Pacific. He will also drive the company’s investor engagement and the execution of future capital markets transactions.
Jeff joins Fullerton Health from WeDoctor, where he served as Chief Strategy Officer, overseeing capital markets strategy, strategic investment and cooperation and international business expansion. Prior to this, he was head of technology investment banking at HSBC and held senior roles within the TMT investment banking team at Credit Suisse in Hong Kong. Jeff holds a Bachelor of Science in Business Administration from the University of Southern California’s Marshall School of Business.
Jeff Chen commented: “I am thrilled to be joining Fullerton Health to work with a strong and deeply knowledgeable team, steering the company’s next phase of growth. I look forward to strengthening relationships with our existing strategic partners and investors in the region, while exploring future opportunities for collaboration and investment across Asia Pacific, which still offers huge growth opportunities in the healthcare space.”
Dr Michael Tan, Co-Founder and Group CEO of Fullerton Health remarked: “With Jeff’s experience and in-depth regional knowledge, he will significantly broaden our ability to drive future growth and international expansion in the region. As we look to address the gaps that prevent people from gaining access to affordable care across Asia Pacific, Jeff’s appointment will help us identify and realise the partnerships and investments to move us closer to this shared goal.”
David Sin, Co-Founder and Group President of Fullerton Health added: “We are delighted to welcome Jeff, whose addition to the Fullerton Health senior team will add focus on driving innovation and technology-driven models of care delivery. This will better position us to pursue opportunities for collaboration with like-minded and forward-thinking companies across the region, particularly in Greater China as we seek to expand our platform and capabilities.”
About Fullerton Health
Fullerton Health is a leading vertically integrated healthcare platform in the Asia Pacific region. Founded in Singapore in 2011, today they serve clients through over 500 healthcare facilities and a large global network of healthcare providers across eight markets in Asia. Fullerton Health’s value proposition is the integration of healthcare service offerings with customized management and advisory capabilities, in line with its mission to transform Asian healthcare and make it affordable and accessible for the patients.
For more information on Fullerton Health, please visit http://www.fullertonhealth.com/.
For more information, please contact:
Group Communications & Relations